Carlo Tanzi | Investor Relations |
Eric Shaff | President and Chief Executive Officer |
Matt Henn | Chief Scientific Officer |
Pam Barrett | Cowen |
Mark Breidenbach | Oppenheimer |
John Newman | Canaccord |
Ladies and gentlemen, thank you for standing by and welcome to the Fourth Quarter Seres Therapeutics Earnings Conference Call. At this time, all participants’ lines are in a listen-only mode. After the speaker’s presentation there will be a question-and-answer session. [Operator Instructions] Please be advised that today’s conference may be recorded. [Operator Instructions]